DMRA
Damora Therapeutics
$26.84
+$0.57 (+2.17%)Sep 10, 2026
Key metrics
The numbers that frame DMRA today
- Market cap
- $1.66B
- P/E (TTM)
- -6.3
- EV / FCF
- -25.1
- ROIC
- 1,686.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.53
- 52wk High
- $38.33
Growth
Revenue and earnings trend for DMRA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DMRA
Is Damora Therapeutics a good buy?
Hold. Damora Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Damora Therapeutics is selling at a very high price.
What is the market capitalization of DMRA?
Damora Therapeutics's market capitalization is $1.66B.
What is the P/E ratio for DMRA stock?
Damora Therapeutics's current P/E ratio is -6.3.
What is the 52-week high for DMRA stock?
The 52-week high for Damora Therapeutics is $38.33. The current close of $26.84 is 30% below that high.
What is the 52-week low for DMRA stock?
The 52-week low for Damora Therapeutics is $2.53. The current close of $26.84 is 960.9% above that low.
Does DMRA stock pay dividends?
Damora Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DMRA?
Damora Therapeutics's Debt / Equity ratio is 0.